CNN3
Calponin-3
Also known as: CNN3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15417
- Gene
- CNN3
- Ensembl
- ENSG00000117519
- Chromosome
- 1
- Canonical length
- 329 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Actin filaments,Cytosol
OverviewNCBI Gene
This gene encodes a protein with a markedly acidic C terminus; the basic N-terminus is highly homologous to the N-terminus of a related gene, CNN1. Members of the CNN gene family all contain similar tandemly repeated motifs. This encoded protein is associated with the cytoskeleton but is not involved in contraction. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
329 residues, UniProt reviewed canonical sequence.
>Q15417|CNN3
1 MTHFNKGPSY GLSAEVKNKI ASKYDHQAEE DLRNWIEEVT GMSIGPNFQL GLKDGIILCE
61 LINKLQPGSV KKVNESSLNW PQLENIGNFI KAIQAYGMKP HDIFEANDLF ENGNMTQVQT
121 TLVALAGLAK TKGFHTTIDI GVKYAEKQTR RFDEGKLKAG QSVIGLQMGT NKCASQAGMT
181 AYGTRRHLYD PKMQTDKPFD QTTISLQMGT NKGASQAGML APGTRRDIYD QKLTLQPVDN
241 STISLQMGTN KVASQKGMSV YGLGRQVYDP KYCAAPTEPV IHNGSQGTGT NGSEISDSDY
301 QAEYPDEYHG EYQDDYPRDY QYSDQGIDYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CNN3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 265 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 265 nTPM
- placenta: 241 nTPM
- lung: 217 nTPM
- blood vessel: 211 nTPM
- endometrium: 202 nTPM
- kidney: 195 nTPM
Single-cell type
- esophageal apical cells: 1,918 nCPM
- hepatic stellate cells: 523 nCPM
- schwann cells: 522 nCPM
- decidual stromal cells: 445 nCPM
- müller glia: 429 nCPM
- salivary ionocytes: 429 nCPM
Immune cell
- naive CD4 T-cell: 12 nTPM
- naive B-cell: 11 nTPM
- naive CD8 T-cell: 8.4 nTPM
- memory B-cell: 4.6 nTPM
- MAIT T-cell: 3.4 nTPM
- total PBMC: 2.6 nTPM
Brain region
- medulla oblongata: 246 nTPM
- hypothalamus: 231 nTPM
- spinal cord: 208 nTPM
- white matter: 189 nTPM
- midbrain: 189 nTPM
- thalamus: 177 nTPM
ReferencesPubMed · IEDB
Publications for CNN3 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Brief Report: Anti-Calponin 3 Autoantibodies: A Newly Identified Specificity in Patients With Sjögren's Syndrome.
2018 · Arthritis Rheumatol · RCR 0.8 · 15 citations - Multi-dimensional immunoproteomics coupled with in vitro recapitulation of oncogenic NRASQ61R identifies diagnostically relevant autoantibody biomarkers in thyroid neoplasia.
2019 · Cancer Lett · RCR 0.5 · 13 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.49
- gnomAD pLI
- 0.6
- gnomAD missense Z
- 2.24
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CNN3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CNN3 as an antibody target. Whether an autoantibody or antibody against CNN3 could matter depends on whether native CNN3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CNN3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CNN3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...